Will certain myeloma drugs respond well if used again for relapse? A patient poses a question about relapse and whether Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasonealone (Decadron) in combination can be used to retreat myeloma. Myeloma expert Dr. Robert Orlowski answers by talking about various studies and examples of patients who responded favorably to Velcade as a stand-alone therapy, then did well when retreated with Velcade once again. Dr. Orlowski speaks about the potential response from the retreatment with various agents, but also points to the potential for resistance.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…